MRI-Derived Radiomics Model to Predict the Biochemical Recurrence of Prostate Cancer Following Seed Brachytherapy.

Our study revealed the considerable potential of a radiomics model based on MRI-derived imaging features in BCR prediction of PCa patients after seed-BT. Radiomics provides a new perspective to clinicians assessing the outcome of radiotherapy, facilitating accurate prognostic evaluation and preoperative consultation for PCa patients followed by seed-BT.